Case Study | Title: Himalaya Drug Company: Anti-Competition

Himalaya Drug Company: Anti-Competition

Content of the study:

Introduction of the concept Anti-Competition.
Various Anti-competitive practices.
Himalaya Drug company – A case study on their anti-competitive activities.
About Amul and its empowerment elements
Factors making Amul an ethical company over its competitors.

Anti-Competitive Practices

The term anti-competitive practice refers to business or government practices that restrict or reduce trade or competition in a given market. Examples of anti-competitive practices include price fixing, bid rigging, boycotts, and tying agreements.

India’s antitrust law, The Competition Act, 2002, was fully constituted on March 1, 2009 – replacing the Monopolistic and Restrictive Trade Practices Act of 1969. The Competition Act monitors any economic activity that monopolizes competition within the market; it aims to protect consumers and small enterprises and ensures the freedom of trade.

Various Anti-competitive practices:

Bid Rigging: Includes agreements between competitors or suppliers that specify how much to bid or when to bid.
Boycotts: Typically includes joint agreements between competitors to not do business with certain competitors, trade partners, or customers.
Disparagement: making false claims or statements about a competitor.
Tying: Agreements between a trade partner and customer that “tie” the purchase of one product or service to an unrelated product or service.
Dividing Territories: Agreements between customers, suppliers, or companies to allocate geographies, customers, or products and services.
Dumping: Includes the sale of a product or service at a loss in a competitive market, with the intent to force competitors out of the market.
Exclusive Dealing: Includes arrangements whereby a retailer or wholesaler purchases from a supplier with the understanding that no other distributor will receive supplies in a given geography.
Price Fixing: Includes agreements between competitors to establish prices, the rate or level of production.
Unethical Collection of Business Intelligence: Includes the use of unlawful or unethical means such as theft, spying, or bribery to collect information about a business.

Read the complete case study here: Case Study on Himalaya Drug Company; Anti-competition

Disclaimer
This report has been produced by students of Global Risk Management Institute for their own research, classroom discussions and general information purposes only. While care has been taken in gathering the data and preparing the report, the student’s or GRMI does not make any representations or warranties as to its accuracy or completeness and expressly excludes to the maximum extent permitted by law all those that might otherwise be implied. References to the information collected have been given where necessary.
GRMI or its students accepts no responsibility or liability for any loss or damage of any nature occasioned to any person as a result of acting or refraining from acting as a result of, or in reliance on, any statement, fact, figure or expression of opinion or belief contained in this report. This report does not constitute advice of any kind.